ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.12749
-0.15%
Brent Oil
84.83
-1.24%
Bitcoin
57,218.65
-5.58%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Precipio Inc (PRPO)

  7. Precipio Inc (PRPO) Noticias

PRPO Precipio Inc

5.7499
0.00 (0.00%)
Pre Mercado
Última actualización: 03:09:35
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Precipio Inc PRPO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 5.7499 03:09:35
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.7499
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/3/202416:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
13/2/202409:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
06/2/202409:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
23/1/202409:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
19/1/202415:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202409:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
04/1/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202416:01EDGAR2Form 8-K - Current report
02/1/202408:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
14/12/202316:00EDGAR2Form 8-K - Current report
14/12/202315:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
16/11/202316:15EDGAR2Form 8-K - Current report
16/11/202316:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
13/11/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202308:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
06/10/202315:34EDGAR2Form 8-K - Current report
03/10/202309:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
28/9/202308:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
25/9/202310:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
21/9/202316:10EDGAR2Form 8-K - Current report
14/9/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202308:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
14/8/202315:00EDGAR2Form 8-K - Current report
11/8/202315:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202316:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
08/8/202308:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
03/8/202308:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
01/8/202308:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
07/7/202315:30EDGAR2Form S-1 - General form for registration of securities under..
14/6/202308:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
13/6/202308:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
08/6/202307:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
07/6/202308:30GLOBEProjected cash burn reduced by $1.5 million annually from..
22/5/202310:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
17/5/202315:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
15/5/202315:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
04/5/202312:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
04/5/202309:00GLOBEPrecipio Signs Another HemeScreen™ Customer

Su Consulta Reciente

NASDAQ
PRPO
Precipio
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados